Conflict of interest declaration: Andrew B Jull

Updated on: 17 February 2021

Roles in: Wounds Group

1. In the past 36 months have you accepted the following from a commercial organisation with a financial interest in the broad topic area of the CRG?

a) Support for attending meetings, including sabbaticals and study tours (this covers travel, accommodation and/or hospitality)?
No

b) Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing, or educational events?
No

c) Fees for organising education?
No

d) Grants and contracts?
No

e) Funds for a member of staff?
No

f) Fees for consulting?
No

g) Royalty or licences payments?
No

h) Payment for expert testimony?
No

i) Payment for a fellowship?
No

j) Payment for participation on a Data Safety Monitoring Board, Advisory Board, or Guideline Panel?
No

k) Payment for a leadership or other fiduciary role in other board, society, committee, or advocacy group?
No

2. In the past 36 months have you, your spouse/partner or an immediate family member been employed by or do you or they own a commercial organization with a financial interest in the broad topic area of the CRG?
No

3. Do you own stocks or shares in a commercial organization with a financial interest in the broad topic area of the CRG?
No

4. Do you hold any patents (planned, issued or pending) for products relevant to the broad topic area of the CRG?
No

5. Do you have any other competing interests (financial or non-financial)?
Yes - Lead author of a trial that has been included in systematic review for which I am the lead author (Honey as topical treatment for wounds). Clinical Advisor to the Health Quality and Safety Commission on national project to introduce surveillance of hospital-acquired pressure injury prevalence (2016-2018). Principal investigator on publicly funded trial (Keratin4VLU) testing a wool-derived keratin dressing. Product provided free of charge by Keraplast Technologies Ltd. Company not involved in conduct or planned analysis of the trial (to be completed September 2019). Principal investigator on publicly funded trial (Factorial4VLU) testing an exercise programme and a hypochlorous acid wound solution. The wound solution and packaging for placebo comparison is provided free of charge by Te Arai BioFarma Ltd. The company is not involved in the conduct or planned analysis of the trial (to be completed September 2022).